Skip to main content
. 2022 May 3;13:852414. doi: 10.3389/fphar.2022.852414

TABLE 4.

Considerations of choosing in selecting drugs (N = 242).

Factors 1 n (%) 2 n (%) 3 n (%) 4 n (%) 5 n (%) Average score
Clinical guideline recommendations 6 (2.48) 2 (0.83) 18 (7.44) 44 (18.18) 172 (71.07) 4.55
Recommended by experts 9 (3.72) 10 (4.13) 58 (23.97) 93 (38.43) 72 (29.75) 3.86
Sufficient clinical evidence 6 (2.48) 8 (3.31) 28 (11.57) 79 (32.64) 121 (50.00) 4.24
Better clinical efficacy 7 (2.89) 4 (1.65) 18 (7.44) 59 (24.38) 154 (63.64) 4.44
Fewer adverse drug reactions 8 (3.31) 5 (2.07) 19 (7.85) 65 (26.86) 145 (59.92) 4.38
Convenient use of dosage forms 9 (3.72) 10 (4.13) 38 (15.7) 73 (30.17) 112 (46.28) 4.11
Smaller drug dose 14 (5.79) 24 (9.92) 59 (24.38) 56 (23.14) 89 (36.78) 3.75
Better drug tastes 22 (9.09) 27 (11.16) 61 (25.21) 51 (21.07) 81 (33.47) 3.59
Better drug appearance 77 (31.82) 51 (21.07) 52 (21.49) 35 (14.46) 27 (11.16) 2.52
Cheaper drug price 19 (7.85) 35 (14.46) 89 (36.78) 49 (20.25) 50 (20.66) 3.31
More plentiful supplies in hospital 20 (8.26) 13 (5.37) 69 (28.51) 64 (26.45) 76 (31.40) 3.67
Patients’ demands 12 (4.96) 29 (11.98) 80 (33.06) 72 (29.75) 49 (20.25) 3.48
High degree of patient recognition 7 (2.89) 17 (7.02) 63 (26.03) 85 (35.12) 70 (28.93) 3.80
Better patient adherence 6 (2.48) 7 (2.89) 43 (17.77) 88 (36.36) 98 (40.50) 4.10

Note: 1 point means very unimportant, 5 points means very important.